Creating Leaner and Meaner Clinical Trials in the Long Run Posted on May 21, 2020June 21, 2021 by Hannah Faulkner Creating Leaner and Meaner Clinical Trials in the Long Run
Will COVID-19 Change How Big Pharma Does Clinical Trials? Posted on May 15, 2020June 21, 2021 by Hannah Faulkner Will COVID-19 Change How Big Pharma Does Clinical Trials?
The Latest Obstacle in the Search for a Coronavirus Treatment: Too Many Drug Trials Posted on April 30, 2020June 21, 2021 by Hannah Faulkner The Latest Obstacle in the Search for a Coronavirus Treatment: Too Many Drug Trials
Pandemic Prompts Trials to Reinvent Themselves, Woodcock Says Posted on April 27, 2020June 21, 2021 by Hannah Faulkner Pandemic Prompts Trials to Reinvent Themselves, Woodcock Says
Manhattan Project approach to COVID-19 could change drug development Posted on April 21, 2020June 21, 2021 by Hannah Faulkner Manhattan Project approach to COVID-19 could change drug development
Clinical Trials Transformation Initiative: A Conversation with Executive Director Dr. Pamela Tenaerts Posted on February 26, 2020June 21, 2021 by Hannah Faulkner Clinical Trials Transformation Initiative: A Conversation with Executive Director Dr. Pamela Tenaerts
Overcoming Barriers in Conducting Decentralized Clinical Trials Posted on February 4, 2020June 21, 2021 by Hannah Faulkner Overcoming Barriers in Conducting Decentralized Clinical Trials
Novel Endpoints in the Digital Age Posted on December 16, 2019June 21, 2021 by Hannah Faulkner Novel Endpoints in the Digital Age
Virtual Clinical Studies: Finding a Path to Execution Posted on December 1, 2019July 9, 2021 by Hannah Faulkner Virtual Clinical Studies: Finding a Path to Execution
Use Commonly Available Data Early to Inform Eligibility and Recruitment, Experts Say Posted on November 8, 2019June 21, 2021 by Hannah Faulkner Use Commonly Available Data Early to Inform Eligibility and Recruitment, Experts Say
